20cm速递|创业板医药ETF国泰（159377）上涨1.1%，政策支持与创新驱动成关注焦点

Group 1 - The pharmaceutical and biotechnology sector has shown strong performance recently, particularly in the medical services and medical devices sub-sectors [1] - The National Healthcare Security Administration has held two meetings to support innovative drugs and medical devices, aiming to accelerate the clinical application of high-level technological innovations [1] - Policies are being implemented to optimize the lifecycle regulation of high-end medical devices, indicating a clear support for innovation in this area [1] Group 2 - The ChiNext Medical ETF (159377) tracks the ChiNext Medical Index (399275), which has seen a 20% change, reflecting the overall performance of listed companies in the biopharmaceutical, medical device, and medical service sectors [1] - The ChiNext Medical Index focuses on companies with high R&D investment and leading technologies, showcasing the innovation and growth characteristics of the pharmaceutical industry on the ChiNext board [1]